Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression

Journal of Clinical Pathology - Molecular Pathology

Volumn 53, Issue 6, 2000, Pages 307-312

  Baker, E A ^a   Bergin, F G ^a   Leaper, D J ^a  

^a UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

Author keywords

Colorectal cancer; Plasminogen activators; Vascular endothelial growth factor

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN;

ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; COLON CARCINOGENESIS; COLORECTAL CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOKINES; NEOPLASM STAGING; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; RECEPTORS, CELL SURFACE; TISSUE PLASMINOGEN ACTIVATOR; TUMOR MARKERS, BIOLOGICAL; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033668753     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.53.6.307     Document Type: Article

References (33)

1. What is the evidence that tumours are angiogenesis dependent?
2. Angiogenesis
3. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer
4. Vascular endothelial growth factor expression correlates with haematogenous metastasis and prognosis in colorectal carcinoma
5. Molecular and biological properties of the vascular endothelial growth factor family of proteins
6. The biology of vascular endothelial growth factor
7. Plasminogen activators, tissue degradation and cancer
8. Role of the contact system in fibrinolysis
9. Fibrinolysis components in breast cancer and colorectal carcinoma
10. Role of urokinase, its receptor and serpins in colorectal carcinoma
11. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumour cells
12. Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer
13. Plasma urokinase receptor levels in patients with colorectal cancer: Relationship to poor prognosis
14. Urokinase plasminogen activator and prognosis in breast cancer
15. Prognostic value of urokinase type plasminogen activator and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas
16. Correlates of urokinase-type plasminogen activator in colorectal cancer: Positive relationship with nm23 and c-erbB-2 protein expression
17. Urokinase type plasminogen activator receptor expression in colorectal neoplasms
18. Urokinase-type plasminogen activator and outcomes in Dukes' B colorectal cancer
19. Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer
20. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
21. Vascular endothelial growth factor increased urokinase receptor expression in vascular endothelial cells
22. Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase type plasminogen activator
23. Involvement of vascular endothelial growth factor and urokinase type plasminogen activator receptor in microvessel invasion in human colorectal cancers
24. A simplified method of quantifying proteins using the biuret and phenol reagents
25. Localisation of urokinase type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans
26. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
27. Antigen levels of urokinase plasminogen activator and its receptor at the tumour-host interface of colorectal adenocarcinomas are related to tumour aggressiveness
28. Urokinase-type plasminogen activator in colorectal cancer: Relationship with clinicopathological features and patient outcome
29. Alterations in plasminogen activation with epithelial cell dysplasia grading in colorectal adenomas
30. Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implication of urokinase in colorectal carcinogenesis
31. Quantitative analysis of vascular endothelial growth factor in colon cancer
32. Vascular endothelial growth factor is up-regulated in early pre-malignant stage of colorectal tumour progression
33. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells